What Matters Most: The Trends That Will Shape Pharma Marketing in 2021
Each year, Intouch creates a “what to watch for” POV to help pharma marketers prepare for the coming year. Here, we explore 5 interrelated aspects of the pandemic’s effects, predict how they will continue to play out in 2021, and recommend how to grow and benefit from them.
Industry Group Will Create New Standards to Protect Ad Practices and Consumers
As the demand for more privacy protections continues, the ad industry moves to create new standards that protect digital advertising practices, including targeting and messaging, while also maintaining consumer privacy.
Intouch Takes Data Security to the Next Level With Two New, Highly Regarded Credentials
Data breaches have become so common, there’s a Wikipedia page devoted to cataloging them – to date, more than 300 breaches are listed. Types of industries affected include hospitality, travel, internet service providers, banking, social media, retail, and of course, healthcare, among others. The massive Equifax breach announced in September 2017 led the Federal Trade […]
Throwback Thursday: 9 Months, 9 Noteworthy Intouch Blogs
As we edge closer to the end of 2019, we wanted to stop and smell the roses, or in this case, indulge in a Throwback Thursday moment and share some of our favorite blog posts from this year. This list represents Intouch’s thinking on a range of topics, from the evolving role of artificial intelligence […]
California’s New Data Privacy Law: New Thinking on its Implications for Pharma
Last fall, we published a POV called “Should Pharma Care About California’s New Data Privacy Law?” Since then, we’ve been monitoring the legislative process and the discussions and reactions of opinion leaders. This updated POV provides the latest thinking on this law and its implications for pharma marketers.
Sensitive Disease State Media Targeting
With the advancement of programmatic media in the pharmaceutical space, many types of targeting are available that can identify and serve pharma ads to the right audiences, both in direct-to-consumer (DTC) and healthcare provider (HCP) advertising. When putting together a media plan for a specific brand, it is important to consider the disease state sensitivity associated with the brand before aligning on targeting tactics.